blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3441086

EP3441086 - ANTI-PD-1 MONOCLONAL ANTIBODY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.10.2022
Database last updated on 27.07.2024
FormerThe patent has been granted
Status updated on  12.11.2021
FormerGrant of patent is intended
Status updated on  16.09.2021
FormerExamination is in progress
Status updated on  13.07.2020
FormerRequest for examination was made
Status updated on  11.01.2019
FormerThe international publication has been made
Status updated on  07.10.2017
Most recent event   Tooltip31.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 03.07.2024  [2024/27]
Applicant(s)For all designated states
Akeso Biopharma, Inc.
6 Shennong Boulevard
Torch developmental Zone
Zhongshan, Guangdong 528437 / CN
For all designated states
Taizhou Hanzhong Biopharmaceutics, Inc.
No.1 of China Medical City Road
Taizhou, Jiangsu 225316 / CN
[2019/07]
Inventor(s)01 / XIA, Yu
6 Shennong Blvd
Torch developmental Zone
Zhongshan Guangdong 528437 / CN
02 / LI, Baiyong
6 Shennong Blvd
Torch developmental Zone
Zhongshan Guangdong 528437 / CN
03 / WANG, Zhongmin Maxwell
6 Shennong Blvd
Torch developmental Zone
Zhongshan Guangdong 528437 / CN
04 / ZHANG, Faming
Biolake B6-515, Eastlake National High-Tech
Development Zone
Wuhan, Hubei 430074 / CN
05 / XI, Gan
Biolake B6-515, Eastlake National High-Tech
Development Zone
Wuhan, Hubei 430074 / CN
06 / HUANG, Ying
Biolake B6-515, Eastlake National High-Tech
Development Zone
Wuhan, Hubei 430074 / CN
 [2019/07]
Representative(s)Rössler, Matthias
karo IP Patentanwälte
Kahlhöfer Rößler Kreuels PartG mbB
Postfach 32 01 02
40416 Düsseldorf / DE
[2021/50]
Former [2019/07]Rössler, Matthias
Kahlhöfer Rößler Kreuels
Patentanwälte PartG mbB
(Karo IP Professionals)
Postfach 32 01 02
40416 Düsseldorf / DE
Application number, filing date16896573.928.10.2016
[2019/07]
WO2016CN103814
Priority number, dateCN20161020774101.04.2016         Original published format: CN201610207741
[2019/07]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017166804
Date:05.10.2017
Language:ZH
[2017/40]
Type: A1 Application with search report 
No.:EP3441086
Date:13.02.2019
Language:EN
[2019/07]
Type: B1 Patent specification 
No.:EP3441086
Date:15.12.2021
Language:EN
[2021/50]
Search report(s)International search report - published on:CN05.10.2017
(Supplementary) European search report - dispatched on:EP14.10.2019
ClassificationIPC:A61K39/395, C07K16/28
[2019/07]
CPC:
C07K16/2818 (EP,CN,US); A61K45/06 (CN); A61P35/00 (EP);
A61P37/04 (EP); A61P43/00 (EP); C07K2317/24 (EP,US);
C07K2317/56 (CN,US); C07K2317/565 (US); C07K2317/74 (EP,US);
C07K2317/76 (EP,US); C07K2317/92 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/07]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:MONOKLONALER ANTI-PD-1-ANTIKÖRPER[2019/07]
English:ANTI-PD-1 MONOCLONAL ANTIBODY[2019/07]
French:ANTICORPS MONOCLONAL ANTI-PD-1[2019/07]
Entry into regional phase25.10.2018Translation filed 
25.10.2018National basic fee paid 
25.10.2018Search fee paid 
25.10.2018Designation fee(s) paid 
25.10.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
25.10.2018Examination requested  [2019/07]
21.04.2020Amendment by applicant (claims and/or description)
16.07.2020Despatch of a communication from the examining division (Time limit: M04)
09.11.2020Reply to a communication from the examining division
25.08.2021Cancellation of oral proceeding that was planned for 15.10.2021
17.09.2021Communication of intention to grant the patent
15.10.2021Date of oral proceedings (cancelled)
04.11.2021Fee for grant paid
04.11.2021Fee for publishing/printing paid
04.11.2021Receipt of the translation of the claim(s)
Opposition(s)16.09.2022No opposition filed within time limit [2022/47]
Fees paidRenewal fee
25.10.2018Renewal fee patent year 03
25.09.2019Renewal fee patent year 04
03.09.2020Renewal fee patent year 05
21.10.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.10.2016
AL15.12.2021
AT15.12.2021
CY15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
MK15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
[2024/27]
Former [2024/21]HU28.10.2016
AL15.12.2021
AT15.12.2021
CY15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2024/18]HU28.10.2016
AL15.12.2021
AT15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2023/25]AL15.12.2021
AT15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2023/01]AL15.12.2021
AT15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/49]AL15.12.2021
AT15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/42]AT15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/36]AT15.12.2021
CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
PT18.04.2022
Former [2022/35]CZ15.12.2021
EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
RO15.12.2021
RS15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
PT18.04.2022
Former [2022/34]EE15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
RO15.12.2021
RS15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
PT18.04.2022
Former [2022/33]HR15.12.2021
LT15.12.2021
LV15.12.2021
RS15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
Former [2022/25]HR15.12.2021
LT15.12.2021
LV15.12.2021
RS15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
Former [2022/24]HR15.12.2021
LT15.12.2021
LV15.12.2021
RS15.12.2021
BG15.03.2022
GR16.03.2022
Former [2022/22]LT15.12.2021
RS15.12.2021
BG15.03.2022
Former [2022/21]RS15.12.2021
BG15.03.2022
Former [2022/19]BG15.03.2022
Documents cited:Search[I]WO2004056875  (WYETH CORP [US], et al) [I] 1-15* examples 1-10; claims 1-34 *;
 [I]WO2006121168  (ONO PHARMACEUTICAL CO [JP], et al) [I] 1-15 * examples 1-25; claims 1-105 *;
 [I]WO2011110621  (UCB PHARMA SA [BE], et al) [I] 1-15 * examples 1-4; claims 1-26 *
ExaminationWO2014055648
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.